Total Funding
57
68
Total FundingPost-IPO Equity raised
Growth Score 57 in past quarter
-7 pts
Heat Score 68 in past quarter
1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
20471
Summit Therapeutics is a clinical-stage drug discovery and development company.
- Ankur Dhingra: Chief Financial Officer
- Laura Chow: Senior Vice President Clinical Development
About the Company
Summit Therapeutics is a clinical-stage drug discovery and development company. The company's new mechanism antibiotics are designed to become the new standards of care for the benefit of patients and create value for payors and healthcare providers.